Mela Sciences, Inc. (MELA) Reports In-Line Q2 Loss; Announces Restructuring
Tweet Send to a Friend
Mela Sciences, Inc. (NASDAQ: MELA) reported Q2 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
